GovChime
Notice ID: fe548cc53268416bb3fe9d6aa0b8b630Award NoticeAwarded

Transgenic Mice

Awarded on August 10, 2021. Full description on SAM.gov.

Awarded tounder 75N95021P00433 (source: SAM.gov award notice)• $28.4K

Overview

Posted
August 10, 2021
Notice type
Award Notice
NAICS
112990: All Other Animal Production
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Place of performance
Baltimore, MD
Last updated
Oct 9, 2026
Award date
Aug 10, 2021
Award amount (SAM.gov award notice)
$28.4K

Identifiers

Solicitation number
75N95021Q00280
Notice ID
fe548cc53268416bb3fe9d6aa0b8b630
Award number (PIID)
75N95021P00433

Description

(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number is 75N95021Q00280 and the solicitation is issued as a request for quotation (RFQ). This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; FAR Subpart 13.5—Simplified Procedures for Certain Commercial Items; and FAR Part 12—Acquisition of Commercial Items and is not expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Institute on Aging (NIA), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to The Jackson Laboratory for Transgenic Mice. This acquisition is conducted as non-competitive for a commercial item or service and is conducted pursuant to FAR 13.106-(b)(1). (iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) Number 2021-06, with effective date July 12, 2021. (iv) The associated NAICS code is 112990 and the small business size standard is $1M. This requirement has no set-aside restrictions. (v) Purchase Description: See Purchase Description attached. (vi) The Government anticipates award of a firm fixed-price purchase order for this acquisition. The delivery will be every 8 weeks between September 1, 2021 to July 1, 2022. (vii) The provision at FAR 52.252-1, Solicitation Provisions Incorporated by Reference (Feb 1998), applies to this acquisition. This solicitation incorporates one or more solicitation provisions by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. The offeror is cautioned that the listed provisions may include blocks that must be completed by the offeror and submitted with its quotation or offer. In lieu of submitting the full text of those provisions, the offeror may identify the provision by paragraph identifier and provide the appropriate information with its quotation or offer. Also, the full text of a solicitation provision may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of provision) The following provisions apply to this acquisition and are incorporated by reference: FAR 52.204-7, System for Award Management (OCT 2018) FAR 52.204-16, Commercial and Government Entity Code Reporting (AUG 2020) FAR 52.212-1, Instructions to Offerors--Commercial Items (JUL 2021) FAR 52.212-3, Offeror Representations and Certifications – Commercial Items (FEB 2021) HHSAR 352.239-73, Electronic and Information Technology Accessibility Notice (December 18, 2015) HHSAR 352.270-5a, Notice to Offerors of Requirement for Compliance with the Public Health Service Policy on Human Care and Use of Laboratory Animals (December 18, 2015) The clause at FAR 52.252-2, Clauses Incorporated by Reference (Feb 1998), applies to this acquisition. This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at these addresses: https://www.acquisition.gov/browse/index/far https://www.hhs.gov/grants/contracts/contract-policies-regulations/hhsar/index.html (End of clause) The following clauses apply to this acquisition and are incorporated by reference: FAR 52.204-13 System for Award Management Maintenance (OCT 2018) FAR 52.204-18 Commercial and Government Entity Code Maintenance (AUG 2020) FAR 52.212-4 Contract Terms and Conditions Commercial Items (OCT 2018) --Addendum to this FAR clause applies to this acquisition and is attached. HHSAR 352.222-70 Contractor Cooperation in Equal Employment Opportunity Investigations (December 18, 2015) HHSAR 352.270-5b, Care of Live Vertebrate Animals (December 18, 2015) The following provisions and clauses apply to this acquisition and are attached in full text. Offerors MUST complete the provisions at 52.204-24 and 52.204-26 and submit completed copies as separate documents with their proposal. FAR 52.204-24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (OCT 2020) FAR 52.204-26 Covered Telecommunications Equipment or Services-Representation (OCT 2020) FAR 52.212-5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (JUL 2021) Invoice and Payment Provisions/Instructions for Submitting Electronic invoices via Email (viii) The provision at FAR clause 52.212-2, Evaluation-Commercial Items (OCT 2014), applies to this acquisition. (a) The Government will award a contract resulting from this solicitation to the responsible offeror whose offer conforming to the solicitation will be most advantageous to the Government, price and other factors considered. The following factors shall be used to evaluate offers: technical capability of the item/service offered to meet the Government requirement; (ii) past performance; and (iii) price. Technical and past performance, when combined, are significantly more important than price. (b) A written notice of award or acceptance of an offer, mailed or otherwise furnished to the successful offeror within the time for acceptance specified in the offer, shall result in a binding contract without further action by either party. Before the offer’s specified expiration time, the Government may accept an offer (or part of an offer), whether or not there are negotiations after its receipt, unless a written notice of withdrawal is received before award. (ix) Offerors shall include a completed copy of the provision at FAR clause 52.212-3, Offeror Representations and Certifications-Commercial Items, with its offer. (x) There are no additional contract requirement(s) or terms and conditions applicable to this acquisition. (xi) The Defense Priorities and Allocations System (DPAS) are not applicable to this requirement. (xii) Responses to this solicitation must include sufficient information to establish the interested parties’ bona-fide capabilities of providing the product or service. The price quote shall include: unit price, shipping and handling costs, prompt payment discount terms, product or catalog number(s), product description, and any other information or factors that may be considered in the award decision. The Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size must be included in the response. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. All quotations must be received by Wednesday, August 4th, 2020 at 3:00 pm Eastern Daylight/Standard Time and must reference solicitation number 75N95021Q00280. Responses must be submitted electronically to Rashiid Cummins, Contract Specialist, at rashiid.cummins@nih.gov Fax responses will not be accepted. (xiii) The name and of the individual to contact for information regarding the solicitation: Rashiid Cummins Contract Specialist rashiid.cummins@nih.gov

Full description on SAM.gov

Award Overview

Award Number

75N95021P00433

Award Amount (SAM.gov award notice)

$28.4K

Award Date

Aug 10, 2021

Awardee

Awardee UEI

XR6LMXNKDJJ1

Awardee CAGE Code

9N885

Original Solicitation

Notice ID: fe548cc53268416bb3fe9d6aa0b8b630

Posted Date: Aug 10, 2021

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

5
  • 75N98027F00001
    JACKSON LABORATORY
    Department of Health and Human ServicesNAICS 112990
    $400.0KSigned Oct 22, 2026
  • HHSF223201400390P
    THE JACKSON LABORATORY
    Department of Health and Human ServicesNAICS 112990
    $27.9KSigned Oct 5, 2026
  • 75N93021F00001
    THE JACKSON LABORATORY
    Department of Health and Human ServicesNAICS 112990
    $18.3KSigned Sep 22, 2026
  • 75R60226P00020
    JACKSON LABORATORY
    Department of Health and Human ServicesNAICS 112990
    $6.1KSigned Sep 1, 2026
  • 75N96021F00002
    JACKSON LABORATORY
    Department of Health and Human ServicesNAICS 112990
    $233.9KSigned Jun 25, 2026

Contacts

Contracting Officer

Primary Contact

Documents

No documents available.

Lifecycle

Solicitation:75N95021Q00280
  1. Market Research
  2. Combined Synopsis
  3. Awarded

This opportunity has been awarded.

  1. Market ResearchJul 6, 2021

    SOURCES SOUGHT: Transgenic Mice

    Notice 3589f7ab0e4f418b84a268ce0887b7d9 on SAM.gov

  2. Combined SynopsisJul 27, 2021

    Transgenic Mice

    Notice 16959f78414747119e91ebc42781924d on SAM.gov

  3. AwardedCurrentAug 10, 2021

    Transgenic Mice

    Notice fe548cc53268416bb3fe9d6aa0b8b630 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q01209/PCA-NIA-08501. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Epigenetic Clock Development Foundation 1124 W. Carson Street, MRL Bldg., 3rd Floor Torrance, CA 90502 US to provide obtain DNA methylation profiling and epigenetic age analysis for 320 previously extracted murine DNA samples using the Mammal320K methylation array and established Horvath epigenetic clock methodologies.
38%
Combined Synopsis09/23/2026
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested, and a separate written solicitation will not be issued. (ii) The solicitation number is 75N98026Q01212/PCA-NIA-08124. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (including brand-name, if applicable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm fix-price award on a non-competitive basis to Metabolon Inc. 617 Davis Drive, Suite 100, Morrisville, NC 27560 to assay global metabolomics data and short chain fatty acids (SCFA) via the Metabolon platform from 369 blood samples in the BLSA. These metabolomics data will be used to identify metabolomic signatures of anthropometric aging quantified via a 3D body scanner.
38%
Combined Synopsis09/23/2026
NOTICE OF AWARD. THIS IS NOT A REQUEST FOR QUOTE/PROPOSALS. On August 8, 2023, in response to the requirements of Solicitation 75N95023Q00368, the National Institute on Drug Abuse (NIDA) awarded Purchase Order No. 75N95023P00520 to Transnetyx, Inc. to acquire Genotyping Services for Transgenic Rats and Mice for HIV Project. An award shall be made on a Firm-Fixed-Price basis. Funding in the amount of $30,000.00 shall be obligated to fully fund this award.
69%
AwardedOpen
Services for Transgenic Development of HIV-related rats
59%
AwardedOpen
50%
AwardedOpen

Additional Details

Solicitation Number

75N95021Q00280

Archive Date

Aug 25, 2021

Office Address

Bethesda, MD, 20892